Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 68 announcements

Zydus Lifesciences Ltd news stories on ALFA NewsRead the news →
Share price
₹1,154.00
Market cap
₹1,16,119 Cr
Revenue (annual)
₹27,148 Cr
Net profit (annual)
₹5,040 Cr
P/E (TTM)
25.7×Sector 47.4×
Promoter holding
75.01%+0.01% QoQ
FII holding
6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:57 IST NSE
Other Announcement

Zydus Lifesciences Other Announcement

Zydus Lifesciences Limited has been assigned an overall ESG rating of 60 by ESG Risk Assessments and Insights Limited (ESGRAIL) based on independent assessment.

19:07 IST NSE
Other Announcement

Zydus Lifesciences Other Announcement

Zydus Lifesciences reported a contra trade violation by a designated person under SEBI PIT Regulations. The profit of Rs. 18,797 was transferred to the IEPF.